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Cell adhesion and migration are key determinants in tumor metastasis. Adherence of tumor cell to the extracellular matrix is
mediated via integrin containing focal adhesions (FAs). Binding of integrins to ECM triggers phosphorylation of two major
components of FAs, focal adhesion kinase (FAK) and Src, activating downstream signaling pathway which leads to FA disassembly
and cell migration. In this paper, we analyze how phosphorylation of FAK regulates its traﬃcking at FAs in living human
astrocytoma cells. Upon pervanadate-induced FAK phosphorylation, phosphorylated FAK appeared highly expressed at newly
formed membrane ruﬄes. This eﬀect was abolished in presence of the speciﬁc Src inhibitor PP2. Our ﬁndings demonstrate that
upon phosphorylation, FAK delocalizes from FAs to membrane ruﬄes.
1.Introduction
During the process of tumor metastasis and more generally
cell migration, cells connect with the microenvironment
in part through focal adhesions (FAs) [1]. FAs transduce
signalsfromtheextracellularmatrixintothecellviaintegrins
clustering and subsequent activation of signaling pathways.
One of the major kinases implicated in FA signaling is focal
adhesion kinase (FAK). FAK contributes to FA scaﬀolding,
and also transmits adhesion-dependent and growth factor-
dependent signals into the cell [2–4]. A major role of FAK
is to inﬂuence the dynamic regulation of integrin-associated
adhesions, and the actin cytoskeleton that is tethered
there, through diverse molecular interactions. This in turn
regulates cell migration by controlling the focal complex
assembly/disassembly cycle at the leading lamellipodia of
migrating cells, while also controlling adhesion disassembly
at the trailing edge.
As FAK−/− ﬁbroblasts show excessive, rather than
decreased, formation of focal contacts, FAK has been asso-
ciated with the disassembly of integrin-based adhesion sites
[5]. Indeed, the apparent rate constants for incorporation
into FAs of paxillin and zyxin, two FA components, were
similar to those observed in wild-type ﬁbroblasts, indicating
that the rate of FA formation is not aﬀected by the absence of
FAK [6]. On the other hand, the FA disassembly in FAK−/−
cells was signiﬁcantly impaired, as the rate constants for the
disassembly of paxillin and zyxin were about 14-fold less in
FAK−/− cells compared to wild-type cells. When FAK was
reintroduced in FAK−/− cells, the rate constant for paxillin
disassembly was comparable to that observed for wild-type
cells [6]. Consistent with the proposal that FAK modulates
adhesionturnover,thenumberofadhesionsthatturnedover
in protrusive regions of FAK−/− cells was markedly less than
in wild-type cells. Taken together, these results show that
FAK is necessary for the eﬃcient disassembly of dynamic
adhesions.
Tyr397 is a major autophosphorylation site in FAK and
phosphorylation at Tyr397 creates a binding site for Src
family kinases and Src homology 2-containing proteins,
suggesting a role of Src in adhesion turnover regulation [3].
Hence, the apparent rate constant for paxillin disassembly
decreased 19-fold in Src/Yes/Fyn-deﬁcient ﬁbroblasts, as
compared to wild-type ﬁbroblasts. Comparable results were2 Journal of Oncology
observed in FAK−/− cells expressing Y397F-FAK [6]. Thus,
a common signaling pathway leading to FA disassembly
appears to require a phosphorylation step. In agreement,
pervanadate-induced hyperphosphorylation of FAK resulted
in the exclusion of FAK from FAs [7]. Moreover, ERK/MAP
kinase phosphorylation is necessary for calpain2 activation
which leads to FA turnover, with the formation of the
active complex consisting of at least ERK/MAP kinase and
calpain2 being driven by the adaptor function of FAK [8].
Several other studies have shown that phosphorylation of
FAK is associated with FA disassembly and thus regulates cell
migration [9–12]. We previously reported the existence of a
rapid ﬂux of FAK between cytosolic and FA compartments
in U87 astrocytoma cells, as revealed by FRAP analysis [13].
Furthermore, phosphorylation of FAK at Tyr397 increases
speciﬁcally the time-residency of FAK at FAs but not in
cytosol,whichinturninducesdisassemblyofFAsasobserved
using Y397F-FAK mutant cells [14]. In order to uncover the
relationship between FAK traﬃcking and phosphorylation
events, we analyzed both the level of FAK phosphorylation
upon pervanadate treatment in diﬀerent cell compartments
and FAK dynamics in living cells. Using this approach, we
demonstrated that increase in FAK phosphorylation induces
delocalization of FAK from FAs to membrane ruﬄes. This
eﬀect was mediated by Src as shown using both selective
inhibitor of Src kinase and overexpression of the kinase dead
mutant of Src (K298M-Src).
2.MaterialsandMethods
2.1. Reagents and Antibodies. Eagle’s minimum essential
medium(EMEM),fetalbovineserum(FBS),ultraglutamine,
penicillin, streptomycin, and trypsin-EDTA solution were
from Lonza. Matrigel and mouse monoclonal antibody (Ab)
directed against FAK kinase domain (amino acids 354–
533) were from BD Biosciences. Polyclonal Abs directed
against the C-terminal (Ct) domain of FAK (amino acids
748–1052) was from Upstate. Antiphospho-Tyr861-FAK (p-
Tyr861) and antiphospho-Tyr397-FAK (p-Tyr397) Abs were
fromBioSource.Anti-SrcAbwasfromBiomolInternational.
Anticortactin was from Millipore. Antivinculin and β-actin
Abs were from Sigma. Phalloidin ﬂuoroProbe547 was from
Interchim. Horseradish peroxidase-conjugated goat anti-
mouse or antirabbit IgG were from Promega. Rhodamine
Red X-conjugated goat antimouse or anti-rabbit Abs were
fromJacksonLaboratories.Proteaseinhibitormixturetablets
and Fugene 6 were obtained from Roche. PP2 and G418
sulfate were from Invitrogen. Pervanadate solution at 1mM
was freshly prepared by mixing vanadate solution (from
Sigma)andhydrogenperoxideinPBStoﬁnalconcentrations
of 1mM and 0.006%, respectively. A ﬁnal concentration of
100μM pervanadate was used to treat the cells.
2.2. Expression Vectors. pcDNA3-FAK/YCam and Y397F-
FAK/YCam were constructed as described previously [14].
The pcDNA3 plasmid containing Y530F-Src was kindly pro-
vided by F. Cruzalegui. All plasmids were isolated using the
JetStar Plasmid kit (Genomed) following the manufacturer’s
protocol.
2.3. Cell Culture and Stable Transfections. U87-MG human
astrocytoma cell line was obtained from the American Type
Culture Collection. Cells were maintained as subconﬂu-
ent monolayers in EMEM supplemented with 10% FBS,
2mM ultraglutamine, 100units/ml penicillin, and 100μg/ml
streptomycin. For stable transfection, cells were ﬁrst trans-
fected using Fugene 6, transfected cells were selected
by ﬂuorescence-activated cell sorting and maintained in
1mg/ml G418 containing medium.
2.4. Immunoblotting. For western blots, FAK/YCam-
expressed cells were plated at low density on dishes
precoated with 178μg/ml Matrigel for 2 days. Cells were
then washed with cold PBS and lysed with ice-cold
RIPA buﬀer (150mM NaCl, 1% Triton X-100, 0.5%
Na deoxycholate, 0.1% SDS, 50mM Tris-HCl, pH 7.5,
and a protease inhibitor mixture tablet). Protein lysates
were resolved by SDS-PAGE and then transferred to
polyvinylidene diﬂuoride membrane (GE healthcare). After
1h blocking at room temperature in 0.1% casein-PBST
(PBS supplemented with 0.1% Tween 20), membranes were
incubated overnight with primary Abs at 4◦C: anti-FAK
kinase (1/1000), anti-FAK Ct (1/1000), antiphospho FAK
(Tyr397 or Tyr861 at 1/2000). Corresponding horseradish
peroxidase-conjugated secondary Abs were used at 1/30000
dilution. Immunoreactivity was visualized using the ECL+
system (GE healthcare).
2.5. Indirect Immunoﬂuorescence and Correlation Analysis.
FAK/YCam-expressing cells were plated at low density on
Matrigel for 2 days before paraformaldehyde ﬁxation, 0.2%
Triton X-100 and blocking with PBS/3% BSA. Cells were
washed with PBS and incubated with primary Abs (1/200)
in PBS/0.2% BSA for 1h. After additional washes, cells were
incubated with rhodamine Red X-conjugated secondary
Abs in PBS/0.2% BSA (1/200), washed with PBS and then
observed using a confocal microscope (Bio-Rad 1024, Kr-Ar
laser; Nikon Eclipse TE300, 60x water-immersion CFI Plan-
Fluor n.a. 1.2 objective). YFP and rhodamine were excited at
488 and 568 nm, respectively, and ﬂuorescence was collected
at 522 (green) and 585nm (red). ImageJ 1.37v software was
used for treatment and analysis of images.
2.6. Live Cell Imaging. FAK/YCam cells plated on Matrigel
for 2 days were submitted to 100μM pervanadate treatment
in phenol-free EMEM supplemented with 10% FCS and
10mM HEPES, prior to imaging by confocal microscopy. Z-
series stacks (0.35μm steps) were acquired every 5 minutes
for 1h at 32
◦C. Representative cells are illustrated from a
minimum of 4 independent experiments. Image J software
was used to assess the dynamics of FAs and membrane
ruﬄes. Automated counting of FAs in single cells was done
after noise removal by thresholding, ﬁltering and applying a
size constraint to FAs. Data are presented as mean ± s.e.m. of
the number of FAs/cell.
2.7. Statistical Analysis. Data were analyzed using Student’s
t-test and diﬀerences were considered to be signiﬁcant at (∗)
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3. Results
3.1. Pervanadate Increases FAK Phosphorylation at FAs.
Previous studies have shown that upon tyrosine phosphory-
lation, FAK was excluded from FAs [7]. We have established
that FAK is implicated in the disassembly of FAs and that
phosphorylation of FAK is the key determinant in the time-
residency of FAK at FAs [14]. In order to determine the eﬀect
of FAK phosphorylation on its subcellular localization, U87-
MG cells stably transfected with FAK/YCam were treated
for the indicated times with pervanadate, a phosphatase
inhibitorknowntoincreaseFAKphosphorylation[7,15,16].
Upon pervanadate treatment, phosphorylation at Tyr397
and Tyr861 of FAK/Ycam occurs in a time-dependent man-
ner (Figure 1). Moreover, pervanadate-dependent increased
phosphorylation of endogenous FAK is also detected, while
the overall amount of FAK remained stable.
3.2. Increased Phosphorylated FAK in Membrane Ruﬄes.
To characterize the eﬀect of FAK hyperphosphorylation
on its subcellular localization, cells grown on Matrigel-
coated imaging dishes were incubated with pervanadate.
Cells expressing exogenous FAK are identiﬁed by emission
of the YFP signal. Immunostaining images show a global
increase in phosphorylated FAK signal intensity as seen in
cells stained for Tyr397 and Tyr861 compared to untreated
cells (Figure 2(a)). At FAs, the ratio of phosphorylated FAK
over total FAK is increased by 3.6-fold for Tyr397 and 2.9-
fold for Tyr861 compared to control cells (Figure 2(b)).
However, FAK staining at FAs was more diﬀuse after PV
treatment, suggesting redistribution of FAK upon phos-
phorylation, as previously described in ﬁbroblasts [7]. As
such, phosphorylated FAK appeared to be highly localized
at membrane ruﬄes after pervanadate, with the ratio of
phosphorylated FAK over total FAK being increased 5.3-fold
for Tyr397 and 4.9-fold for Tyr861 compared to control cells.
Of note, the enhanced localization of FAK in membrane
ruﬄes was not as clear in cells visualized by YFP signal. One
possible explanation might be that FAK phosphorylation
induces cleavage of FAK with the N-terminus of FAK which
contains the YFP moiety thus being no longer addressed
to FAs. However, immunostaining experiments with Abs
against the kinase, Ct or FAT domains of FAK did not
reveal more intense FAK staining at membrane ruﬄes
after pervanadate (not shown). Our results suggest that a
small fraction of FAK localizes at membrane ruﬄes that is
highly phosphorylated, which is consistent with high FAK
activity.
3.3.IncreaseFADisassemblyuponFAKHyperphosphorylation.
To further determine whether the localization of FAK is
indeed sensitive to tyrosine phosphorylation, time-lapse
imaging on live FAK/Ycam cells was carried out. Cells
were treated with pervanadate and observed over a 1 hour
period (Figure 3(a)). Several FAs underwent disassembly
during pervanadate-induced FAK hyperphosphorylation.
Quantiﬁcation of FA dynamics revealed a decrease in the
number of FAs per cell (Figure 3(b))a sw e l la sa no v e r a l l
decrease in the ﬂuorescence intensities of FAs (not shown)
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Figure 1: Pervanadate increases FAK phosphorylation at FAs.
FAK/Ycam expressed U87-MG cells were treated with 100μM
pervanadate (PV) for the indicated time (minutes). Western
blots probed with phospho-speciﬁc FAK Abs (against Tyr397
and Tyr861) showed time-dependent increase in phosphorylation.
Endogenous FAK was detected at 125 KDa, and exogenous FAK
at 200KDa. Total amount of FAK was veriﬁed by stripping and
probing with Ab against the Ct domain of FAK. Quantiﬁed
numbers between blots correspond to the endogenous and exoge-
nous phospho-FAK signal intensities normalized to total FAK.
Quantiﬁcations were done using Image J software.
after PV treatment, that were sometimes accompanied by
clear cellular movements (Figure 3). Out of the 30% of cells
analyzed, a complete loss of FAs was observed 1h after per-
vanadate.Theseresultssuggestthathyperphosphorylationof
FAK leads ﬁrst to the exclusion of FAK from FAs followed by
disassembly of FAs.
3.4. Decreased Colocalization of FAK to Vinculin after
Pervanadate Treatment. In order to test this hypothesis,
immunostaining experiments were done on cells treated for
20 minutes with PV and labeled for FAK and vinculin, a
marker of FAs. FAK and vinculin completely colocalized at
FAs in untreated cells (arrowheads, Figure 4), while some
peripheral FAs stained only for vinculin and not FAK in PV
treated cells (arrows, Figure 4). Moreover, ventral FAs were
marked only for FAK and not vinculin (Figure 4). These
observationswereconﬁrmedbyquantiﬁcationanalysisusing
Pearson’s coeﬃcient that determines the degree of overlap
between two paired images (Figure 4). The coeﬃcient is
relatively high in control cells (R = 0.68 ± 0.01, n = 20)
but signiﬁcantly lower in PV-treated cells (R = 0.59 ± 0.02,
n = 22).4 Journal of Oncology
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Figure 2: Increased phosphorylated FAK in membrane ruﬄes upon PV treatment. (a) Cells expressing FAK/Ycam were treated with vehicle
or PV for 20 minutes, PFA ﬁxed and immunostained with phospho-speciﬁc FAK (Tyr397 and Tyr861) Abs. Note the increase in global
ﬂuorescenceinPVtreatedcells.Arrowheadsindicatethepresenceofphospho-FAKinmembraneruﬄes.Scalebar,10μm.(b)Graphspresent
p-Y397-FAK and p-Y861-FAK intensities relative to total FAK intensity (YFP). Data are means ± s.e.m. from 6 independent experiments.
3.5. Increase FAK at Cell Membrane. In order to correlate
membrane ruﬄe formation and localization of hyperphos-
phorylated FAK, FAK/Ycam cells were incubated with PV
and followed by time-lapse imaging. After 30 minutes, cells
were ﬁxed, and labeled for phospho-Tyr397-FAK. Of note,
while 75% of cells presented no change in membrane ruﬄe
formation in PV-treated cells, the remaining 25% showed
FAK disassembly together with membrane ruﬄe formation
(Figure 5(a)). To examine whether newly formed ruﬄes
contained phosphorylated FAK, PV-treated cells were ﬁxed,
permeabilized and labeled for phospho-Tyr397-FAK. Results
revealed that phospho-Tyr397 is detected at FAs but also
at membrane ruﬄes (Figure 5(b)), indicating that activated
FAK was present in membrane ruﬄes. Intensity analysis of
the cell membrane region pointed by an arrowhead showed
a signiﬁcant increase in phosphorylated FAK over total FAK
(60.3 and 39.59 maximal ﬂuorescence intensities, resp.).
3.6. Src-Dependent Localization of FAK. Our observations
indicate that tyrosine phosphorylation of FAK induces
delocalization of FAK from FAs to membrane ruﬄes since
increased phosphorylated FAK was found at membrane
ruﬄes after PV treatment (Figure 2). Phosphorylation of
FAK at Tyr397 creates a binding site for Src, which in
turn phosphorylates the other tyrosine residues of FAK. It
has been reported that Tyr861 is a Src-speciﬁc substrate
[17, 18]. In agreement, we now report that in human
astrocytomas, U87 cells treated with PP2, a selective Src
inhibitor, showed a signiﬁcant decrease in phosphorylation
of FAK at Tyr861 (Figure 6(a)). Moreover, transfection of
these cells with the constitutively active form of Src, Src-
Y530F, results in an increase in FAK-Tyr861 phosphorylation
levels (Figure 6(b)). This demonstrated that Tyr861 is a
Src-speciﬁc target in human astrocytomas and therefore
suggests that FAK translocation from FAs to membraneJournal of Oncology 5
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Figure 3: Analysis of FA behavior upon FAK hyperphosphorylation. (a) Confocal time-lapse images of FAK/Ycam expressed cells were
collected every 5 minutes for 1 hour after PV addition. Confocal images of living cells at 0, 20, 40, and 60 minutes are shown. Arrowheads,
labeled 1 to 4, indicate areas of FA disassembly. Scale bar, 10μm. (b) Image J software was used to apply a ﬁlter and a size constraint to FAs
and the image shown results from the merging of images at t = 60 (black) and t = 0 (white). Newly formed FA (black) and dissociated FA
(white). Graph represents the number of FA/cell that was measured by the segmentation/size criteria process both before PV (t = 0, white
bar) and after 60 minutes PV treatment (t = 60, black bar) from 8 cells (mean ± s.e.m.). Note the signiﬁcant decrease in the number of FAs
in cells treated with PV compared to untreated cells (P<. 05).
ruﬄes may be a consequence of Src activity and one
of the ﬁrst steps in oncogenic transformation. Indeed,
cellular localization of phosphorylated FAK shows either
membrane localization (Figure 6(c) top panels) compa-
rable with that observed after pervanadate treatment or
invadopodia localization (Figure 6(c) bottom panels). The
invadopodia are characterized by localization of the speciﬁc
marker cortactin (Figure 6(c)). This diﬀerence in localiza-
tion may depend on the stage of oncogenic transforma-
tion.6 Journal of Oncology
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Figure 4: Colocalization of FAK and vinculin. After PV treatment,
cells were ﬁxed and immunolabeled for vinculin (Rhodamine
Red-X). Arrowheads point to FAs in untreated cells and arrows
point to FAs in cells treated for 20 minutes with PV. Inserts are
magniﬁed images of indicated boxed regions. Note the reduction
in the degree of colocalization of FAK (green) with vinculin (red)
at FAs (arrows). Quantiﬁcation of colocalization was determined
by Pearson’s coeﬃcient using Image J software and the graph
represents means ± s.e.m. of more than 20FAs analyzed per
condition.
4. Discussion
Tyrosine phosphorylation is clearly implicated in the
turnover of FAs, yet the molecular mechanism underlying
this process is still obscure. We previously described a rapid
ﬂux of FAK between FAs and cytosol [13]. Increasing FAK
phosphorylation led to increased time-residency of FAK
at FAs, whereas decreasing phosphorylation gave rise to a
decreased time-residency [14]. Macroscopically, the conse-
quence of FAK hypophosphorylation is a decrease in global
FA turnover as reported in several studies using Y397F-
FAK [6, 14, 19]. Src family kinases have been implicated
in phosphorylation-induced exclusion of FAK from FAs
[7], but the relationships between FAK phosphorylation,
FAK traﬃcking and FA turnover have never been described.
In this study, we analyzed FAK traﬃcking upon FAK
phosphorylation and demonstrated that phosphorylated
FAK was translocated from FAs to membrane ruﬄes via
presumably a Src-dependent mechanism, leading in turn to
FA disassembly and formation of membrane ruﬄes. This
process links the eﬀects of FAK in promoting integrin-
stimulated cell motility to the implication of FAK in cell
invasion [20, 21].
Coordinated disassembly of FAs is known to be required
for eﬃcient cell migration, yet the process of FA disassembly
is only poorly understood. The relative lack of information
reﬂects that FA disassembly and assembly occur simultane-
ously,anduntilrecently,modelsystemsinwhichdisassembly
is kinetically separated from assembly were unavailable. To
circumvent this, recent studies have employed a method
allowing coordination of FA disassembly [14, 19]. The
strategyisbasedonearlierobservationsthatshowedgrowing
microtubules transiently contacting FAs and inducing their
disassembly [22]. Nevertheless, despite the clear insights
provided by the “nocodazole wash-out” model [22] in the
mechanism of FA disassembly, some important pathways
were apparently not required. For example, Src family
kinases were found not to be essential in microtubule-
induced FA disassembly [19] contrarily to what has been
demonstrated for adhesion turnover in migrating ﬁbroblasts
[6, 12] or colon carcinoma cells [23]. Therefore, we used
another strategy based on FAK phosphorylation in order
to better visualize and analyze FA disassembly. Indeed, FAK
phosphorylation appears to be a major and obligatory step
in this process [12–14, 19, 21, 24]. After pervanadate, FAK
is hyperphosphorylated [7, 15], leading to an increased cell
ratio content of phosphorylated FAK over FAK, and thereby
allowing analysis of the cellular localization of phosphory-
lated FAK. Indeed, our immunoﬂuorescence experiments in
pervanadate-treated cells reveal a membrane localization of
phosphorylated FAK that was hardly detected by visualizing
the YFP moiety of the FAK/YCam chimera (Figure 2(a)).
Upon pervanadate treatment, FAK is ﬁrst delocalized from
FAs as demonstrated with colocalization analysis of FAK
and vinculin and after the phosphorylation process. This is
consistent with the gradual disassembly of FA observed upon
pervanadate treatment (Figure 5). Hence, these data provide
strong, yet indirect, evidence for molecular changes at FAs,
starting with high FAK phosphorylation and followed by FA
disassembly and p-FAK traﬃcking to membrane ruﬄes.
The question now is to explain what might be the
biological signiﬁcance of high phosphorylated FAK at mem-
branes ruﬄes. Recently, Tyr397, the autophosphorylation
site of FAK was shown to be essential for the spatial
organization of the leading edge of migrating cells [25].
FAK and its phosphorylation process has also been shown
to be necessary for lamellipodial formation and progres-
sion [26, 27] and tyrosine phosphorylation of FAK has
been associated with lamellipodial progression in human
neuroblastoma cells. Moreover, stable localization of FAK
at FAs has been observed in migrating ﬁbroblasts, as well
as transient recruitment of FAK to lamellipodial extensions
with formation of a signaling complex including FAK, Src,
p130Cas and Dock 180, involved in cell invasion [20].
Therefore, phosphorylated FAK at membrane ruﬄes might
be one of the early steps in the process of oncogenic
transformation. Indeed, when U87 cells are transfected withJournal of Oncology 7
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Figure 5: Increased phosphorylated FAK at cell membrane. (a) Images of PV-treated cells were taken by confocal microscopy at 5 minutes
intervals for 30 minutes, then cells were ﬁxed and immunolabeled for p-Tyr397-FAK (Rhodamine Red-X). Scale bar, 20μm. Note membrane
ruﬄe formation (arrowheads) and loss of FAs (arrows) upon addition of PV. Moreover, membrane ruﬄes show strong P-Tyr397-FAK
labeling (right panel, red). (b) Boxed regions in panel (a) are magniﬁed in panel (b) and correspond to FAK/Ycam (green) and p-Tyr397-
FAK (red) signals at 30 minutes after PV. Fluorescence intensity analyses were quantiﬁed at the membrane region. Fluorescence intensity
was measured along the 10μm line (red) using Plot Proﬁle, Image J software, with grey values ranging from 0 to 256. Note the increase in
phospho-FAK signal at the cell membrane compared to total FAK (maximal intensities indicated by black arrowheads).
the constitutive active form of Src, these cells displayed
increased level of phosphorylated FAK at tyr861, and a
transformed phenotype characterized by the presence of
podosomesasalreadydescribed[28].Becauseofthepresence
of markers of FAK activation in podosomes [29], we believe
that upon Src activation, early changes in the cell phenotype
involve loss of focal adhesions and ruﬄe formation, and
subsequently, formation of podosomes. Accordingly, using
a temperature-sensitive mutant of Src, actin rearrangement
has been followed upon switch from the restrictive to the
permissive temperature [30]. In this study, formation of Src-
containing membrane ruﬄes was evident 16 hours after the
switch.
In conclusion, in response to migration- and invasion-
associated stimuli, high levels of Src expression and activity
in tumor cells allows for a positive FAK-Src feedback
loop leading to subsequent phosphorylation of FAK. Phos-
phorylated FAK shuttles rapidly from FAs to membrane
ruﬄes, which may be one way for cells to enhance highly
dynamic turnover of FAs and to relocalize adhesion proteins
into nascent adhesions formed at the lamellipodia. Our
ﬁndings provide new insights into the molecular mechanism
involving FAK phosphorylation in promoting tumor cell
migration. Thus, targeting of FAK phosphorylation may be
a strategical basis for cancer treatment. Recently, several
small molecular inhibitors have been developed that target8 Journal of Oncology
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Figure 6: Eﬀects of Src on phosphorylated FAK. (a) Western blots done on U87 cell lysates incubated with or without 10μM PP2 for 30
minutes and probed for p-Y861-FAK and total FAK. P-Tyr861 decreased after PP2, consistent with Src activity being necessary for Tyr861
phosphorylation.(b)U87cellstransientlyexpressingY530F-Src.Blotswereprobedforp-Y861FAKandtotalFAK.Totalamountsofproteins
in panels (a) and (b) were monitored by stripping and blotting for β-actin. (c) Cells expressing transiently Y530F-Src (red) were ﬁxed,
immunostainedfor p-Y861-FAK (green),and cortactin (blue), usedas a marker for invadopodia. Arrowheads showregions of colocalization
of p-Tyr861-FAK, Src, and cortactin at invadopodia and cell membrane.
speciﬁcally the Y397 autophosphorylation of FAK, such as
TAE226, a compound that shows eﬀective inhibition of
angiogenesis, and tumor growth when treated in combina-
tion with imatinib [31, 32]. The promising inhibitor Y15
speciﬁcally blocks FAK autophosphorylation and thus its
overall phosphorylation, leading to cell detachment and
pancreatic tumor regression in vivo [33, 34].
Abbreviation
Ab: antibody
YFP: yellow ﬂuorescent protein
FA: focal adhesion
FAK: focal adhesion kinase
PV: pervanadate
YCam: yellow cameleon.
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